FINWIRES · TerminalLIVE
FINWIRES

$SNDL

3 stories mentioning SNDL

Every FINWIRES story that references SNDL, newest first.

Wire

Tilray Brands Says Cannabis Rescheduling Furthers Research, Access; Shares Rise Pre-Bell

Tilray Brands (TLRY) said Thursday that the Trump administration's move to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act furthers medical cannabis clinical research, patient access, and industry standardization.The rescheduling represents an inflection point for US drug policy, and Tilray will participate in the emerging regulated medical cannabis market in the country, the company said.Shares of Tilray Brands were up 14% in Thursday premarket trading.Other cannabis stocks like Canopy Growth (CGC), Cronos (CRON), High Tide (HITI), SNDL (SNDL), and Aurora Cannabis (ACB) were also higher following the news of cannabis rescheduling.

$ACB$CGC$CRON$HITI$SNDL$TLRY
Wire

Market Chatter: US Expected to Ease Restrictions on Cannabis as Early as Wednesday

The US Department of Justice is expected as soon as Wednesday to lower cannabis' classification into a less-restrictive federal category, Bloomberg reported Wednesday, citing a person familiar with the matter.The move would shift cannabis to Schedule III from Schedule I, the government's most restrictive class, the report said, citing the person.The White House didn't immediately respond to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $7.69, Change: $+0.80, Percent Change: +11.58%

$CRON$HITI$IIPR$SNDL$TLRY
Wire

US Expected to Ease Restrictions on Cannabis as Early as Wednesday, Bloomberg Reports

US Expected to Ease Restrictions on Cannabis as Early as Wednesday, Bloomberg Reports

$CRON$HITI$IIPR$SNDL$TLRY